|
Mr. Brand brings 16 years of pharmaceutical experience with 11 years Neuroscience experience. As VP, Global Commercial Strategy Neuroscience, GlaxoSmithKline PLC (GSK), Mr. Brand was responsible for commercial development of GSK�s phase I III Neuroscience pipeline. In addition, Mr. Brand oversaw global commercialization for marketed CNS products to include Paxil /CR, Wellbutrin /XL, Zyban, Lamictal, Imitrex and Requip. As Paxil marketing director, Mr. Brand managed GSK�s largest asset achieving gross sales of $1.8 billion and was recognized as one of Advertising Age�s Top 100 Marketers (2000). An experienced executive, Mr. Brand has managed multiple co-promotions / co-development partnerships and brings extensive lifecycle management and market development experience | 